Concord Drugs fundamental analysis
CONCORD
86
2.89 (3.48%)Last updated on 30 Dec, 2025 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Concord Drugs Fundamentals
P/E Ratio
190.1
P/B Ratio
2.38
Div. Yield
0
Sector P/E
69.94
Sector P/B
1.03
Sec. Div. Yield
0.56
Concord Drugs Fundamentals is currently trading with a P/E Ratio of 190.1, compared to the sector average of 69.94. Its P/B Ratio stands at 2.38, while the sector’s is 1.03. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Concord Drugs Score Card
Price
Expensive
Growth
Good
Quality
Poor
Management
Poor
On its scorecard, Concord Drugs reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
